Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Heidt

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Transplantation|August 10, 2019
Donor-specific B Cell Memory in Alloimmunized Kidney Transplant Recipients: First Clinical Application of a Novel MethodCaroline Wehmeier, Gonca E Karahan, Juliette Krop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2021
Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus ReplicationNatasja G de Groot, Corrine M C Heijmans, Suzanne Bezstarosti, et al.
HLA|January 19, 2024
Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodiesCynthia S M Kramer, Suzanne Bezstarosti, Marry E I Franke-van Dijk, et al.
Journal of Virology|May 14, 2003
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapyBianca Heemskerk, Louise A Veltrop-Duits, Tamara van Vreeswijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 29, 2020
Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DRCynthia S M Kramer, Marry E I Franke-van Dijk, Kim H Bakker, et al.
British Journal of Clinical Pharmacology|November 21, 2022
Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantationTom C Zwart, Suzanne Bezstarosti, Federica R Achini, et al.
Frontiers in Immunology|January 30, 2023
Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoidsLonneke H Gaykema, Rianne Y van Nieuwland, Mette C Dekkers, et al.
Transplant Immunology|May 11, 2021
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidneyKoen E Groeneweg, Fréderique A van der Toorn, Dave L Roelen, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
JHEP Reports : Innovation in Hepatology|April 4, 2022
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitisMaaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Transplantation|August 10, 2019
Donor-specific B Cell Memory in Alloimmunized Kidney Transplant Recipients: First Clinical Application of a Novel MethodCaroline Wehmeier, Gonca E Karahan, Juliette Krop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2021
Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus ReplicationNatasja G de Groot, Corrine M C Heijmans, Suzanne Bezstarosti, et al.
HLA|January 19, 2024
Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodiesCynthia S M Kramer, Suzanne Bezstarosti, Marry E I Franke-van Dijk, et al.
Journal of Virology|May 14, 2003
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapyBianca Heemskerk, Louise A Veltrop-Duits, Tamara van Vreeswijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 29, 2020
Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DRCynthia S M Kramer, Marry E I Franke-van Dijk, Kim H Bakker, et al.
British Journal of Clinical Pharmacology|November 21, 2022
Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantationTom C Zwart, Suzanne Bezstarosti, Federica R Achini, et al.
Frontiers in Immunology|January 30, 2023
Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoidsLonneke H Gaykema, Rianne Y van Nieuwland, Mette C Dekkers, et al.
Transplant Immunology|May 11, 2021
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidneyKoen E Groeneweg, Fréderique A van der Toorn, Dave L Roelen, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
JHEP Reports : Innovation in Hepatology|April 4, 2022
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitisMaaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
Pageof 15